GPR139

GPR139(G 蛋白偶联受体 139)是一种由 GPR139 基因编码的人类蛋白质。GPR139 是一种在中枢神经系统中表达的孤儿 G 蛋白偶联受体。

GPR139 的表达模式主要在 mRNA 水平上进行研究,并主要在中枢神经系统中表达。

GPR139 是一种通过对人类基因组的生物信息学分析而确定的孤儿受体。因此,GPR139 是治疗帕金森病、肥胖症、饮食失调和/或糖尿病的潜在靶点。

GPR139 专门在与运动控制相关的大脑区域表达。GPR139 的功能和信号转导途径难以捉摸,文献中的结果甚至相互矛盾。GPR139 激动剂以剂量依赖性方式保护原发性多巴胺能 (DA) 神经元免受 MPP+ 毒性的损害。

GPR139 (G protein-coupled receptor 139) is a protein that in humans is encoded by the GPR139 gene. GPR139 is an orphan G-protein–coupled receptor expressed in the central nervous system.

The expression pattern of GPR139 has primarily been studied on the mRNA level and showed expression mainly in the central nervous system.

GPR139 is an orphan receptor identified from bioinformatics analysis of the human genome. GPR139 is thus a potential target for the treatment of Parkinson’s disease, obesity, eating disorders, and/or diabetes.

The GPR139 is expressed specifically in the brain in areas of relevance for motor control. GPR139 function and signal transduction pathways are elusive, and results in the literature are even contradictory. GPR139 agonists dose-dependently protect primary dopaminergic (DA) neurons against MPP+ toxicity.

共 2种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
LP-471756

LP-471756 是一种有效的 GPR139 拮抗剂,IC50 值为 640 nM,可抑制 LP-360924 刺激的 cAMP 产生。

413605-11-5
Antagonist
99.53%
LP-471756
NCRW0005-F05

NCRW0005-F05 是一种有效的 GPR139 拮抗剂(IC50 为 0.21 μM),可用于糖尿病、肥胖症和帕金森的研究。

342779-66-2
Antagonist
99.94%
NCRW0005-F05

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础